Type I Interferons Suppress Anti-Parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis
Cell Reports - United States
doi 10.1016/j.celrep.2020.01.099
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Elsevier BV